A global view on carbapenem-resistant Acinetobacter baumannii

mBio. 2023 Dec 19;14(6):e0226023. doi: 10.1128/mbio.02260-23. Epub 2023 Oct 26.

Abstract

Carbapenem-resistant Acinetobacter baumannii are of increasing public health importance, as they are resistant to last-line antibiotics. International clones with well-characterized resistance genes dominate globally; however, locally, other lineages with different properties may be of importance to consider. This study investigated isolates from a broad geographic origin from 114 hospitals in 47 countries and from five world regions ensuring the greatest possible diversity in an organism known for its propensity for clonal epidemic spread and reflecting the current global epidemiology of carbapenem-resistant A. baumannii. In Latin America, a lineage different from other geographic regions circulates, with a different resistance gene profile. This knowledge is important to adjust local infection prevention measures. In a global world with migration and increasing use of antimicrobials, multidrug-resistant bacteria will continue to adapt and challenge our healthcare systems worldwide.

Keywords: Acinetobacter baumannii; carbapenem resistance; carbapenemase; genome analysis; international clone; molecular epidemiology.

MeSH terms

  • Acinetobacter Infections* / epidemiology
  • Acinetobacter Infections* / microbiology
  • Acinetobacter baumannii* / drug effects
  • Acinetobacter baumannii* / genetics
  • Acinetobacter baumannii* / isolation & purification
  • Anti-Bacterial Agents* / pharmacology
  • Carbapenems* / pharmacology
  • Drug Resistance, Multiple, Bacterial / genetics
  • Global Health*
  • Humans
  • Microbial Sensitivity Tests
  • beta-Lactam Resistance / genetics

Substances

  • Carbapenems
  • Anti-Bacterial Agents